The medical spa industry sits at the intersection of healthcare and luxury wellness, offering minimally invasive aesthetic treatments such as injectables, laser therapy, body contouring, and medical-grade skincare under physician supervision. The sector has experienced explosive growth driven by increasing consumer acceptance of aesthetic procedures, social media influence, and the premiumization of wellness spending. The lower middle market is highly fragmented, with thousands of independent owner-operated locations representing significant consolidation opportunity for regional and national roll-up platforms.
Who buys these: Private equity-backed roll-up platforms, strategic acquirers in aesthetics or dermatology, entrepreneurial physicians and nurse practitioners, and individual investors with healthcare or beauty industry backgrounds seeking cash-flowing service businesses
3.5–6×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Minimum $300K–$500K EBITDA, established patient database of 1,000+ active clients, recurring revenue via membership programs, licensed medical director in place, clean compliance history, and located in a high-income or growing suburban market
Get Deal Flow In Your Inbox
New Med Spa acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Med Spa acquisition
Seller Intelligence
Who sells Med Spa businesses?
Owner-operator physicians, nurse practitioners, and aesthetics entrepreneurs who founded or built med spas over 5–15 years, seeking liquidity, retirement, burnout relief, or partnership with a larger platform to scale
Typical exit timeline: 12–18 months
Med Spa businesses in the $1M–$5M revenue range typically sell for 3.5–6× EBITDA. Minimum $300K–$500K EBITDA, established patient database of 1,000+ active clients, recurring revenue via membership programs, licensed medical director in place, clean compliance history, and located in a high-income or growing suburban market
Med Spa businesses typically trade at 3.5–6× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Med Spa businesses are SBA 7(a) eligible, making them accessible to first-time buyers. SBA 7(a) loan with 10–20% buyer equity injection, seller note for 5–10% to bridge valuation gap
Key due diligence areas include: State-specific corporate practice of medicine compliance and medical director agreement structure; Provider dependency analysis — concentration of revenue tied to individual injectors, aestheticians, or physicians; Equipment inventory, age, lease vs. owned status, and upcoming capital expenditure requirements for device upgrades; Deferred revenue liability from pre-sold packages and membership obligations on the balance sheet; Malpractice claims history, patient complaint records, and insurance coverage adequacy.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers